banner
Raf inhibitor LXH254, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ980

Raf inhibitor LXH254, Purity ≥98%

Synonym: LXH254; Naporafenib; 1800398-38-2; LXH-254; N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide; LXH254 free base; Raf inhibitor

  • CAS Number: 1800398-38-2
  • Compound CID: 90456533
img
Product Size
2 mg; 5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
LXH254, soluble in DMSO and ethanol and insoluble in water, blocks a MAPK/ERK signaling pathway. It targets Abl1, ARAF, B-Raf, and CRAF.
Molecular Weight
502.49
Molecular Formula
C25H25F3N4O4
Targets
Abl1: 4.9 μM; ARAF: 6.4 nM; B-Raf: 0.21 nM; CRAF: 0.072 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 85 mg/mL (169.15 mM); Water: Insoluble; Ethanol: 29 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
LXH254 can be utilized to explore its dual inhibition of BRAF and CRAF in cancer models.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0